Central Nervous System Drugs Global Market Report 2022

Mar 2022| TBR333F| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Drug Type: Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Alzheimer; Diabetic Neuropathy; Other CNS drugs
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
4) By Route Of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Biogen Inc.; Johnson & Johnson; Novartis AG; UCB S.A.; Takeda Pharmaceuticals; AbbVie; Teva Pharmaceuticals; GlaxosmithKline; Daiichi Sankyo Company; H Lundbeck

Central Nervous System Drugs Global Market Report 2022 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global central nervous system drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the central nervous system drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Central Nervous System Drugs Market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider central nervous system drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The central nervous system drugs market section of the report gives context. It compares the central nervous system drugs market with other segments of the central nervous system drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, central nervous system drugs indicators comparison.

 

 

Scope

Markets Covered:

  • By Type: Pharmaceutical Drugs; Biologics
  • By Drug Type: Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Alzheimer; Diabetic Neuropathy; Other CNS drugs
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • By Route Of Administration: Oral; Parenteral; Others
  • By Drug Classification: Branded Drugs; Generic Drugs
  • By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Biogen Inc.; Johnson & Johnson; Novartis AG; UCB S.A.; Takeda Pharmaceuticals

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4 : Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5 : Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Central Nervous System Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 13 : Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global
  • Table 14 : Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 15 : Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 16 : Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 17 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 18 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
  • Table 19 : Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20 : China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21 : China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22 : Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23 : Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24 : Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25 : India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26 : India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27 : Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28 : Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29 : Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30 : Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31 : Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32 : New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33 : Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34 : Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35 : South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36 : Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37 : Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 38 : Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 39 : Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 40 : Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 41 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 42 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
  • Table 43 : Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44 : Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45 : Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46 : Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47 : Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48 : France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49 : France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50 : Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51 : Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52 : Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53 : Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54 : Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55 : Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56 : Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57 : Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58 : Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59 : Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60 : UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 61 : UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 62 : Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 63 : Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 64 : Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 65 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 66 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
  • Table 67 : Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68 : Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69 : Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70 : Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 71 : Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 72 : Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 73 : North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 74 : North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 75 : North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 76 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
  • Table 77 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
  • Table 78 : North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79 : Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 80 : Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 81 : USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 82 : USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 83 : South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 84 : South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 85 : South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 86 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
  • Table 87 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
  • Table 88 : South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89 : Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90 : Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91 : Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 92 : Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 93 : Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 94 : Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95 : Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 96 : Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 97 : Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 98 : Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 99 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 100 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
  • Table 101 : Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 102 : Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 103 : Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104 : Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105 : UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106 : Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 107 : Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 108 : Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 109 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
  • Table 110 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
  • Table 111 : Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 112 : Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 113 : Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 114 : South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 115 : Biogen Inc Financial Performance
  • Table 116 : Johnson & Johnson Financial Performance
  • Table 117 : Novartis AG Financial Performance
  • Table 118 : UCB S.A. Financial Performance
  • Table 119 : Takeda Pharmaceuticals Financial Performance
  • Table 120 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 121 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 122 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 123 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 124 : Global Central Nervous System Drugs Market In 2026- Growth Countries
  • Table 125 : Global Central Nervous System Drugs Market In 2026- Growth Segments
  • Table 126 : Global Central Nervous System Drugs Market In 2026- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Central Nervous System Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4 : Global Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5 : Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Central Nervous System Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Central Nervous System Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : Central Nervous System Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 13 : Per Capita Average Central Nervous System Drugs Market Expenditure, 2016-2026, Global
  • Figure 14 : Asia-Pacific, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 15 : Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 16 : Asia-Pacific, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 17 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 18 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Asia-Pacific Countries
  • Figure 19 : Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20 : China Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21 : China Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22 : Australia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23 : Australia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24 : Hong Kong Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25 : India Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26 : India Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27 : Indonesia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28 : Indonesia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29 : Japan Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30 : Japan Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31 : Malaysia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32 : New Zealand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33 : Philippines Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34 : Singapore Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35 : South Korea Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36 : Thailand Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37 : Vietnam Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 38 : Western Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 39 : Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 40 : Western Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 41 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 42 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Western Europe Countries
  • Figure 43 : Western Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44 : Austria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45 : Belgium Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46 : Denmark Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47 : Finland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48 : France Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49 : France Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50 : Germany Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51 : Germany Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52 : Ireland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53 : Italy Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54 : Netherlands Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55 : Norway Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56 : Portugal Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57 : Spain Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58 : Sweden Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59 : Switzerland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60 : UK Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 61 : UK Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 62 : Eastern Europe, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 63 : Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 64 : Eastern Europe, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 65 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 66 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Eastern Europe Countries
  • Figure 67 : Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68 : Czech Republic Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69 : Poland Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70 : Romania Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 71 : Russia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 72 : Russia Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 73 : North America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 74 : North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 75 : North America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 76 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, North America Countries
  • Figure 77 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, North America Countries
  • Figure 78 : North America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79 : Canada Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 80 : Mexico Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 81 : USA Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 82 : USA Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 83 : South America, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 84 : South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 85 : South America, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 86 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, South America Countries
  • Figure 87 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, South America Countries
  • Figure 88 : South America Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89 : Argentina Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90 : Brazil Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91 : Brazil Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 92 : Chile Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 93 : Colombia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 94 : Peru Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95 : Venezuela Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 96 : Middle East, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 97 : Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 98 : Middle East, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 99 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 100 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Middle East Countries
  • Figure 101 : Middle East Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 102 : Saudi Arabia Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 103 : Israel Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104 : Turkey Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105 : UAE Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106 : Africa, Central Nervous System Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 107 : Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 108 : Africa, Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 109 : Per Capita Average Central Nervous System Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 110 : Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2021, Africa Countries
  • Figure 111 : Africa Central Nervous System Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 112 : Egypt Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 113 : Nigeria Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 114 : South Africa Central Nervous System Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 115 : Biogen Inc Financial Performance
  • Figure 116 : Johnson & Johnson Financial Performance
  • Figure 117 : Novartis AG Financial Performance
  • Figure 118 : UCB S.A. Financial Performance
  • Figure 119 : Takeda Pharmaceuticals Financial Performance
  • Figure 120 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 121 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 122 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 123 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 124 : Global Central Nervous System Drugs Market In 2026- Growth Countries
  • Figure 125 : Global Central Nervous System Drugs Market In 2026- Growth Segments
  • Figure 126 : Global Central Nervous System Drugs Market In 2026- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Central Nervous System Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

  • Date - Oct 2021
  • Code - TBR333E

Including: 1) By Type: Multiple Sclerosis (MS); Anti-Psychotic; Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Anti-Depressants; Other CNS Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Intravenous; Intranasal/ Inhalation; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Biogen Inc.; Johnson ...

Central Nervous System Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • Date - Feb 2021
  • Code - TBR333D

Including: 1) By Type: Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: Biogen Inc; F. Hoffmann-La Roche Ltd; Johnson ...

Central Nervous System Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery

  • Date - Jun 2020
  • Code - TBR333C

Including: Analgesics; Anti-Epileptics; Anesthetics; Anti-Parkinson drugs; Other CNS drugs

The global central nervous system drugs market is expected to decline from $118.1 billion in 2019 to $115.3 billion in 2020 at a CAGR of -2.4%, this is due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 outbreak.. The ...

Central Nervous System Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

  • Date - May 2020
  • Code - TBR333B

Including: 1) By Type: Analgesics; Anti-Parkinson drugs; Anesthetics; Anti-Epileptics; Other CNS drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: Biogen Inc; F. Hoffmann-La Roche Ltd; Johnson & Johnson; Pfizer Inc; ...

Central Nervous System Drugs Global Market Report 2019

  • Date - Jan 2019
  • Code - TBR333A

Including: Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs

Covering: Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

The Business Research Company
Price: $4000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS